ABSTRACT
The increase in the number of diseases resulting from exposure to carcinogenic, mutagenic, reprotoxic substances, or endocrine disruptors, as well as nanomaterials is a worldwide problem. It happens not only because of the chemical substances present in the work environment known for many years, but also because of new potential risks that are emerging. From this point of view, it seems extremely important to properly manage the risks associated with their use, production, and processing.
